ELF1 and colorectal carcinoma: In the current study we identify TM9SF2 as an oncogene that is most likely regulated by the transcription factor ELF1. Our findings provide a rationale for exploring the efficacy of drugs targeting either TM9SF2 or ELF1 for treating advanced-stage CRC.